---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284437535.md"
description: "BioLineRx shares are trading higher after the company announces that the first patient has been dosed in its Phase 1/2A study of GLIX-1 for glioblastoma and other high-grade gliomas."
datetime: "2026-04-28T18:41:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284437535.md)
  - [en](https://longbridge.com/en/news/284437535.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284437535.md)
---

# 

BioLineRx shares are trading higher after the company announces that the first patient has been dosed in its Phase 1/2A study of GLIX-1 for glioblastoma and other high-grade gliomas.

### Related Stocks

- [BLRX.US](https://longbridge.com/en/quote/BLRX.US.md)
- [LBRX.US](https://longbridge.com/en/quote/LBRX.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [BioLineRx starts Phase 1/2a trial of GLIX1 in recurrent glioblastoma](https://longbridge.com/en/news/286900261.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)